Jagsonpal Pharmaceuticals (JAGSNPHARM.NS) Earnings Analysis
Jagsonpal Pharmaceuticals (JAGSNPHARM.NS) has no confirmed upcoming earnings date. Trailing P/E 34.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does JAGSNPHARM.NS next report earnings?
No confirmed upcoming earnings date is currently scheduled for JAGSNPHARM.NS. This page updates as the calendar is published.
JAGSNPHARM.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 1.25 INR | n/a | n/a | n/a |
| 2026-01-20 | 1.67 INR | n/a | n/a | n/a |
| 2025-10-21 | 1.88 INR | n/a | n/a | n/a |
| 2025-01-22 | 4.74 INR | n/a | n/a | n/a |
| 2024-10-23 | 1.72 INR | n/a | n/a | n/a |
JAGSNPHARM.NS valuation and analyst view
| Trailing P/E | 34.00 |
|---|---|
| Trailing EPS | 6.146 INR |
| Price / book | 5.52 |
| Dividend yield | 1.15% |
| Market cap | 14.50B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jagsonpal Pharmaceuticals (JAGSNPHARM.NS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for JAGSNPHARM.NS. This page updates as the calendar is published.
Did JAGSNPHARM.NS beat earnings last quarter?
Consensus estimate data was not available for JAGSNPHARM.NS's 2026-05-04 report.
What is JAGSNPHARM.NS's current P/E ratio and EPS?
JAGSNPHARM.NS trades at a trailing P/E of 34.00 on trailing EPS of 6.146086554593077 INR.
What do analysts rate JAGSNPHARM.NS?
JAGSNPHARM.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.